C-arms are imaging devices that work on the principles of X – ray technology. C-Arms have two key components: X – ray detector and X – ray source. C-Arms provide high resolution real time X – ray images, which help physicians monitor the surgery and make critical corrections where necessary and reduce the chances for follow up surgeries.
The global fluoroscopy and c-arms market is estimated to account for US$ 4,897.6 Mn in terms of value by the end of 2027.
Global Fluoroscopy and C-Arms Market: Drivers
Increasing adoption of fluoroscopy and c-arms is expected to propel growth of the global fluoroscopy and c-arms market over the forecast period. For instance, in November 2018, Agfa US Corp. was awarded a group purchasing agreement with Premier, which allowed Premier members, at their discretion, to take advantage, of special pricing and terms pre-negotiated by Premier for Agfa's comprehensive line of Direct Radiography (DR) systems.
Moreover, high prevalence of orthopedic diseases is also expected to propel growth of the global fluoroscopy and c-arms market over the forecast period. For instance, according to the study, “Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017”, published in the journal Annals of the Rheumatic Diseases, in November 2019, the age-standardized point prevalence and annual incidence rates of RA were 246.6 and 14.9 in 2017, which increased by 7.4% and 8.2% from 1990, respectively.
North America held dominant position in the global fluoroscopy and c-arms market in 2019, accounting for 37.7% share in terms of value, followed by Europe and Asia Pacific, respectively.
Figure 1: Global Fluoroscopy and C-Arms Market Share (%) Value, By Region, 2019
Global Fluoroscopy and C-Arms Market: Restraints
Adoption of alternative techniques to fluoroscopy is expected to hinder growth of the global fluoroscopy and c-arms market. Fluoroscopy techniques allow surgeons to perform minimally invasive surgical procedures. However, fluoroscopy involves risk from ionizing radiation due to which several physicians prefer use of alternative techniques such as ultrasound, which provides similar modalities.
Moreover, increasing availability of refurbished equipment is also expected to limit growth of the global fluoroscopy and c-arms market. The demand for refurbished equipment is higher among the end users, owing to high price of the fluoroscopy devices and C – arms. This in turn is expected to boost demand for refurbished equipment. The price of refurbished C – arms may range from US$ 5,000 to US$ 140,000 whereas the price of new C – arm may reach up to US$ 200,000.
Fluoroscopy and C-Arms Market Report Coverage
||Market Size in 2019:
||US$ 3,417.0 Mn
|Historical Data for:
||2016 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 4,897.6 Mn
- North America: U.S., Canada
- Latin America: Brazil, Argentina, Mexico, Rest of Latin America
- Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
- Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
- Middle East: GCC Countries, Israel, Rest of Middle East
- Africa: North Africa, Central Africa, South Africa
- By Product Type:
- C-Arms: Full Size C - arms, Mini C - arms.
- Fluoroscopy Devices
- By End User: Hospitals, Specialty Clinics, Diagnostic Centers.
GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Hologic, Inc., and Ziehm Imaging
- Increasing prevalence of chronic diseases
- Approval and launch of new products
|Restraints & Challenges:
Global Fluoroscopy and C-Arms Market: Opportunities
Use of artificial intelligence with fluoroscopy is expected to offer lucrative growth opportunities for players in the global fluoroscopy and c-arms market. For instance, in October 2019, a study presented at the American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting and Postgraduate Course, reported that using a fluoroscopy system enabled with artificial intelligence (AI) during image-guided endoscopy can significantly reduce patients’ exposure to radiation and diminish the scatter effect to endoscopy personnel.
Moreover, development of technology that reduces patient exposure to radiation is also expected to aid in growth of the global fluoroscopy and c-arms market. For instance, in May 2020, Corindus, a Siemens Healthineers company, announced that findings from the study published in Circulation: Cardiovascular Interventions demonstrated that robotic PCI with the CorPath GRX System reduces patient exposure to radiation by 20% compared to manual PCI with no increase in fluoroscopy time or contrast utilization.
The global fluoroscopy and c-arms market was valued at US$ 3,417.0 Mn in 2019 and is forecast to reach a value of US$ 4,897.6 Mn by 2027 at a CAGR of 4.6% between 2020 and 2027.
Figure 2: Global Fluoroscopy and C-Arms Market Value (US$ Mn), 2016 – 2027
Market Trends/Key Takeaways
Increasing adoption of fluoroscopy and c-arms is expected to propel growth of the global fluoroscopy and c-arms market over the forecast period. For instance, in November 2019, AIIMS Bhopal, a hospital in India, inaugurated state of the art Digital Radiography Fluoroscopy unit in the hospital.
Major players in the global fluoroscopy and c-arms market are focused on approval and launch of new devices to expand their product portfolio. For instance, in March 2018, Philips received the U.S. Food and Drug Administration’s clearance for ProxiDiagnost N90, a digital radiography-fluoroscopy system.
Global Fluoroscopy and C-Arms Market: Competitive Landscape
Major players operating in the global fluoroscopy and c-arms market include, GE Healthcare, Koninklijke Philips N.V. Siemens Healthineers, Hologic, Inc., and Ziehm Imaging.
Global Fluoroscopy and C-Arms Market: Key Developments
Major players in the global fluoroscopy and c-arms market are focused on adopting collaboration and partnership strategies to enhance their market share. For instance, in July 2020, Turner Imaging Systems entered into a Master Resellers agreement, which will add the Smart-C Mini C-Arm to the Siemens Healthineers portfolio of radiology and imaging products.